ArticleEFSA journal. European Food Safety Authority2025
Welfare of horses during killing for purposes other than slaughter.
Article in EFSA journal. European Food Safety Authority, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Estimating the welfare impacts of differing projectile types utilised for stranded cetacean euthanasia.Scientific reports · 2026Article
- An assessment of cetacean welfare in the Faroe Islands' drive hunt.Biology letters · 2025Article
- Welfare of beef cattle.EFSA journal. European Food Safety Authority · 2025Article
- Plain Language Summary of the Scientific opinion on welfare of horses during on-farm killing for purposes other than slaughter.EFSA journal. European Food Safety Authority · 2025Article
- Welfare of horses during killing for purposes other than slaughter.EFSA journal. European Food Safety Authority · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Horses of different ages may have to be killed on-farm for purposes other than slaughter (where slaughter is defined as killing for human consumption) either individually (i.e. on-farm killing of unproductive, injured or terminally ill animals) or on a large-scale (i.e. depopulation for disease control purposes and other situations, such as environmental contamination, disaster management, etc.). The purpose of this opinion is to assess the hazards and welfare consequences associated with the on-farm killing of horses. The killing procedure is divided into Phase 1 (pre-killing), which includes the processes (i) handling and moving the animals to the killing place and (ii) restraint of the animals before application of the killing method; and Phase 2 (stunning and/or killing), which includes stunning and killing of the animals (for methods that require one step for stunning and another for subsequent killing) or killing only (for methods that simultaneously stun and kill the animals). Three stunning and/or killing methods for Phase 2 for horses were identified: (i) penetrative captive bolt followed by killing, (ii) firearms with free projectiles and (iii) lethal injection. Welfare consequences that horses may experience during each process (e.g. handling stress, restriction of movement and injuries during restraint) were identified and potential hazards are listed for all phases, along with preventive and corrective measures. Animal-based measures (ABMs) to assess all identified welfare consequences were proposed. During the application of the stunning and/or killing methods, horses will experience pain and fear if they are ineffectively stunned/killed or if they recover consciousness. A flowchart including ABMs for the assessment of consciousness and death to monitor stunning and killing effectiveness is provided. Additionally, specific practices deemed unacceptable on welfare grounds are listed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.